219 related articles for article (PubMed ID: 30066399)
1. Infusion of ex-vivo expanded human TCR-αβ
Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
[TBL] [Abstract][Full Text] [Related]
3. Human LAP
Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
[TBL] [Abstract][Full Text] [Related]
4. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
6. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-modulated dendritic cells delay lethal graft-versus-host disease through induction of regulatory T cells.
Vanherwegen AS; Cook DP; Ferreira GB; Gysemans C; Mathieu C
J Steroid Biochem Mol Biol; 2019 Apr; 188():103-110. PubMed ID: 30605776
[TBL] [Abstract][Full Text] [Related]
8. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
[TBL] [Abstract][Full Text] [Related]
9. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
[TBL] [Abstract][Full Text] [Related]
10. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
11. Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.
Hannon M; Lechanteur C; Lucas S; Somja J; Seidel L; Belle L; Bruck F; Baudoux E; Giet O; Chantillon AM; Delvenne P; Drion P; Beguin Y; Humblet-Baron S; Baron F
Transfusion; 2014 Feb; 54(2):353-63. PubMed ID: 23772685
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.
Trenado A; Sudres M; Tang Q; Maury S; Charlotte F; Grégoire S; Bonyhadi M; Klatzmann D; Salomon BL; Cohen JL
J Immunol; 2006 Jan; 176(2):1266-73. PubMed ID: 16394018
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
[TBL] [Abstract][Full Text] [Related]
15. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
[TBL] [Abstract][Full Text] [Related]
16. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.
Juvet SC; Zhang L
J Mol Cell Biol; 2012 Feb; 4(1):48-58. PubMed ID: 22294241
[TBL] [Abstract][Full Text] [Related]
17. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells.
Voelkl S; Gary R; Mackensen A
Eur J Immunol; 2011 Mar; 41(3):739-48. PubMed ID: 21287552
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of regulatory T cells for clinical applications against graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Zhang LF; Xia CQ
Chin Med J (Engl); 2013 Dec; 126(23):4575-82. PubMed ID: 24286428
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function.
Ulbar F; Montemurro T; Jofra T; Capri M; Comai G; Bertuzzo V; Lavazza C; Mandelli A; Viganò M; Budelli S; Bacalini MG; Pirazzini C; Garagnani P; Giudice V; Sollazzo D; Curti A; Arpinati M; La Manna G; Cescon M; Pinna AD; Franceschi C; Battaglia M; Giordano R; Catani L; Lemoli RM
J Transl Med; 2019 Aug; 17(1):250. PubMed ID: 31383037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]